Should I buy or sell Veeva Systems stock right now?

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" VEEV shares. View VEEV analyst ratings or view top-rated stocks .

What is Veeva Systems' stock price target for 2024?

20 brokers have issued 1 year target prices for Veeva Systems' shares. Their VEEV share price targets range from $160.00 to $270.00. On average, they predict the company's stock price to reach $234.90 in the next year. This suggests a possible upside of 17.2% from the stock's current price. View analysts price targets for VEEV or view top-rated stocks among Wall Street analysts .

How have VEEV shares performed in 2024?

Veeva Systems' stock was trading at $192.52 at the start of the year. Since then, VEEV stock has increased by 4.1% and is now trading at $200.38. View the best growth stocks for 2024 here .

When is Veeva Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 29th 2024. View our VEEV earnings forecast .

How were Veeva Systems' earnings last quarter?

Veeva Systems Inc. (NYSE:VEEV) announced its quarterly earnings data on Thursday, February, 29th. The technology company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.81 by $0.11. The technology company earned $630.62 million during the quarter, compared to the consensus estimate of $620.75 million. Veeva Systems had a trailing twelve-month return on equity of 11.26% and a net margin of 22.24%.

What ETFs hold Veeva Systems' stock?

ETFs with the largest weight of Veeva Systems (NYSE:VEEV) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) , Sterling Capital Focus Equity ETF (LCG) , Fidelity Digital Health ETF (FDHT) , Direxion Daily Cloud Computing Bull 2x (CLDL) , ARK Genomic Revolution ETF (ARKG) , VanEck Morningstar ESG Moat ETF (MOTE) , VanEck Morningstar Wide Moat ETF (MOAT) and Goldman Sachs Future Health Care Equity ETF (GDOC) .

What guidance has Veeva Systems issued on next quarter's earnings?

Veeva Systems issued an update on its first quarter 2025 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of 1.420-1.430 for the period, compared to the consensus EPS estimate of 1.270. The company issued revenue guidance of $640.0 million-$643.0 million, compared to the consensus revenue estimate of $645.8 million.

What is Peter Gassner's approval rating as Veeva Systems' CEO?

202 employees have rated Veeva Systems Chief Executive Officer Peter Gassner on Glassdoor.com . Peter Gassner has an approval rating of 82% among the company's employees.

What other stocks do shareholders of Veeva Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Veeva Systems investors own include NVIDIA (NVDA) , Alibaba Group (BABA) , Salesforce (CRM) , PayPal (PYPL) , Shopify (SHOP) , Walt Disney (DIS) , Adobe (ADBE) , Netflix (NFLX) , Trade Desk (TTD) and Block (SQ) .

Who are Veeva Systems' major shareholders?

Veeva Systems' stock is owned by many different institutional and retail investors. Top institutional shareholders include Los Angeles Capital Management LLC (0.09%), Rockland Trust Co. (0.06%), Thomasville National Bank (0.05%), Gateway Investment Advisers LLC (0.03%), Congress Asset Management Co. MA (0.02%) and Selective Wealth Management Inc. (0.02%). Insiders that own company stock include Alan Mateo , Eleni Nitsa Zuppas , Jonathan Faddis , Joseph Christopher Hays, Mary Lynne Hedley , Matthew J Wallach, Matthew J Wallach , Michele O'connor , Paul Edward Chamberlain , Paul J Sekhri , Peter P Gassner , Ronald E F Codd , Steven L Fasman, Thomas D Schwenger and Timothy S Cabral . View institutional ownership trends .

How do I buy shares of Veeva Systems?

Shares of VEEV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Veeva Systems have any subsidiaries?

The following companies are subsidiares of Veeva Systems: AdvantageMS, Learnaboutgmp, Physicians World, Selligy, Veeva Crossix, Veeva RTSM, Veracity Logic, and Zinc Ahead Ltd. Read More

Most-Upgraded StocksMost-Upgraded

NYSE:VEEV

Veeva Systems (VEEV) Stock Price, News & Analysis

→ Can't believe it's happening again (From Manward Press) (Ad)

Free VEEV Stock Alerts

$200.38

-1.24 (-0.62%)

(As of 04/16/2024 ET)

Compare

Today's Range: $199.55
▼
$202.49
50-Day Range: $201.62
▼
$234.79
52-Week Range: $160.21
▼
$236.90

Volume: 1.42 million shs
Average Volume: 989,776 shs
Market Capitalization: $32.33 billion

P/E Ratio: 62.23
Dividend Yield: N/A
Price Target: $234.90

Get Veeva Systems alerts:

Veeva Systems MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.65 Rating Score
Upside/Downside: 17.2% Upside
$234.90 Price Target
Short Interest: Healthy
1.48% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.79
Upright™ Environmental Score
News Sentiment: 0.74
Based on 11 Articles This Week
Insider Trading: Selling Shares
$3.84 M Sold Last Quarter
Proj. Earnings Growth: 14.36%
From $4.11 to $4.70 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.71 out of 5 stars

Computer And Technology Sector

42nd out of 590 stocks

Prepackaged Software Industry

11th out of 199 stocks

3.3

Analyst's Opinion

Consensus Rating
Veeva Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.65, and is based on 14 buy ratings, 5 hold ratings, and 1 sell rating.
Amount of Analyst Coverage
Veeva Systems has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

4.0

Short Interest

Percentage of Shares Shorted
1.48% of the outstanding shares of Veeva Systems have been sold short.
Short Interest Ratio / Days to Cover
Veeva Systems has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Veeva Systems has recently decreased by 3.24%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Veeva Systems does not currently pay a dividend.
Dividend Growth
Veeva Systems does not have a long track record of dividend growth.

2.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Veeva Systems has received a 24.04% net impact score from Upright. Veeva Systems seems to create the most significant positive value in categories "Jobs", "Taxes", and "Knowledge infrastructure". The positive contribution in the "Knowledge infrastructure" impact category is false driven by its "Hosted data storage services", "Application hosting services", and "Hosted analytics services" products. See details.
Environmental Sustainability
The Environmental Impact score for Veeva Systems is -0.79.

2.6

News and Social Media Coverage

News Sentiment
Veeva Systems has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Computer and Technology companies.
News Coverage This Week
MarketBeat has tracked 11 news articles for Veeva Systems this week, compared to 11 articles on an average week.
Search Interest
Only 18 people have searched for VEEV on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.
MarketBeat Follows
17 people have added Veeva Systems to their MarketBeat watchlist in the last 30 days. This is an increase of 31% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Veeva Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,836,900.00 in company stock.
Percentage Held by Insiders
10.98% of the stock of Veeva Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
88.20% of the stock of Veeva Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Veeva Systems are expected to grow by 14.36% in the coming year, from $4.11 to $4.70 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Veeva Systems is 62.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 138.71.
Price to Earnings Ratio vs. Sector
The P/E ratio of Veeva Systems is 62.23, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 238.16.
Price to Earnings Growth Ratio
Veeva Systems has a PEG Ratio of 2.09. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Veeva Systems has a P/B Ratio of 6.96. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Veeva Systems Stock (NYSE:VEEV)

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

VEEV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VEEV Stock News Headlines

March 17, 2024 | insidertrades.com

Veeva Systems Inc. (NYSE:VEEV) Director Timothy S. Cabral Sells 15,000 Shares

April 13, 2024 | americanbankingnews.com

Veeva Systems Inc. (NYSE:VEEV) Receives Average Rating of "Moderate Buy" from Brokerages

April 16, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 12, 2024 | americanbankingnews.com

Veeva Systems (NYSE:VEEV) Upgraded at StockNews.com

April 10, 2024 | markets.businessinsider.com

Veeva Systems: Poised for Growth with Strong Market Position and Competitive Edge

April 10, 2024 | fool.com

2 Healthcare Stocks to Buy Hand Over Fist in April

April 9, 2024 | bizjournals.com

Mental health provider shutters Redwood City operations

April 9, 2024 | markets.businessinsider.com

Maintaining Hold on Veeva Systems Amid New Salesforce Competition and Market Uncertainty

April 16, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 9, 2024 | markets.businessinsider.com

Maintaining Leadership: Buy Rating Affirmed for Veeva Systems Amid Competitive Pressures

April 4, 2024 | bizjournals.com

Zendesk's long-time Mid-Market headquarters listed for sale

April 3, 2024 | finance.yahoo.com

Is Veeva Systems (VEEV) a Good Investment Bet?

April 2, 2024 | finance.yahoo.com

Veeva Systems Inc.: Veeva: Leadership Transition Doesn’t Alter Our Favorable Long-Term Outlook

April 2, 2024 | msn.com

Why Veeva Systems Shares Are Diving Tuesday

April 2, 2024 | finance.yahoo.com

Veeva Systems Stock Falls 7% After Finance Chief Steps Down

April 2, 2024 | msn.com

Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS

April 1, 2024 | prnewswire.com

Veeva Vault CRM Now Available for All New Customers

April 1, 2024 | finance.yahoo.com

Veeva Systems Inc.'s (NYSE:VEEV) Intrinsic Value Is Potentially 26% Above Its Share Price

March 31, 2024 | seekingalpha.com

Veeva: Clinical Trial Platform Monopoly With Huge Untapped Opportunities

March 28, 2024 | benzinga.com

$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today

March 28, 2024 | benzinga.com

Peering Into Veeva Systems's Recent Short Interest

March 28, 2024 | seekingalpha.com

Veeva Systems: A Jewel In Transition

March 27, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO) and Veeva Systems (VEEV)

March 27, 2024 | finance.yahoo.com

Global Electronic Trial Master File Systems Market Analysis Report 2024-2030: Delivery Modes, Clinical Trials Phases, and Regional Expansion

March 27, 2024 | finance.yahoo.com

Veeva Systems (VEEV) Fell on Revenue Guidance

March 25, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Amgen (AMGN) and Petiq (PETQ)

March 20, 2024 | finanznachrichten.de

Veeva Systems: Veeva Vault EDC Surpasses 1,000 Study Start Milestone

See More Headlines

Receive VEEV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veeva Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/29/2024
Today: 4/16/2024
Next Earnings (Estimated): 5/29/2024
Fiscal Year End: 1/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Computer and Technology
Industry: Prepackaged software
Sub-Industry: N/A
Current Symbol: NYSE:VEEV
CUSIP: N/A
CIK: 1393052
Web: www.veeva.com
Phone: (925) 452-6500
Fax: 925-452-6504
Employees: 7,172
Year Founded: 2007

Price Target and Rating

Average Stock Price Target: $234.90
High Stock Price Target: $270.00
Low Stock Price Target: $160.00
Potential Upside/Downside: +16.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.65
Research Coverage: 20 Analysts

Profitability

EPS (Most Recent Fiscal Year): $3.22
Trailing P/E Ratio: 62.61
Forward P/E Ratio: 49.06
P/E Growth: 2.09
Net Income: $525.71 million
Net Margins: 22.24%
Pretax Margin: 24.88%
Return on Equity: 11.26%
Return on Assets: 9.01%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.24
Quick Ratio: 4.24

Sales & Book Value

Annual Sales: $2.36 billion
Price / Sales: 13.76
Cash Flow: $3.40 per share
Price / Cash Flow: 59.27
Book Value: $28.80 per share
Price / Book: 7.00

Miscellaneous

Outstanding Shares: 161,320,000
Free Float: 143,604,000
Market Cap: $32.53 billion
Optionable: Optionable
Beta: 0.74

Social Links

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Peter P. Gassner (Age 59)
Founder, CEO & Director
Comp: $391.67k
Mr. Thomas D. Schwenger (Age 56)
President & COO
Comp: $391.67k
Mr. Brent R. Bowman (Age 57)
Chief Financial Officer
Comp: $391.67k
Mr. Jonathan W. Faddis (Age 52)
Senior VP, General Counsel & Corporate Secretary
Comp: $391.67k
Ms. Eleni Nitsa Zuppas (Age 54)
Chief Marketing Officer
Comp: $391.67k
Ms. Kristine B. Diamond (Age 56)
Principal Accounting Officer
Mr. Pinal Patel
Chief Information Officer
Mr. Gunnar Georg Hansen
Director of Investor Relations
Mr. Jacques Mourrain Ph.D.
Vice President of Quality & Compliance
Mr. Alan V. Mateo (Age 62)
Executive Vice President of Global Sales
Comp: $350k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

Veeva Systems provides cloud-based software tailored for the life sciences industry, offering solutions like Veeva Commercial Cloud and Veeva Vault PromoMats, catering to the specific needs of pharmaceutical and biotechnology companies.
Veeva's suite of software includes Veeva customer relationship management (CRM) which enables customer-facing employees to enhance interactions with clients, potentially leading to increased sales and customer satisfaction.
The company's focus on analytics solutions like Veeva Crossix and Veeva OpenData can provide valuable insights for pharmaceutical brands, aiding in strategic decision-making and market positioning.
Veeva's diverse product offerings, such as Veeva Vault Medical and Veeva Link, showcase the company's commitment to innovation and addressing the evolving needs of the life sciences industry.
Considering the recent positive market sentiment towards Veeva Systems, reflected in its stock price performance, investors may find potential for capital appreciation and returns on their investment.

Cons

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

While Veeva Systems has shown strong performance, the competitive landscape in the cloud-based software industry, especially in the life sciences sector, could pose challenges for sustained growth and market share expansion.
Market volatility and fluctuations in the technology sector may impact Veeva's stock price, potentially leading to short-term uncertainties for investors.
Regulatory changes or shifts in the healthcare industry could affect Veeva's business operations and product demand, introducing risks related to compliance and market dynamics.
Investors should carefully assess Veeva's financial metrics, market positioning, and growth strategies to ensure alignment with their investment objectives and risk tolerance.
External factors like global economic conditions or geopolitical events may influence Veeva Systems' performance and stock price, requiring investors to stay informed and proactive in their investment decisions.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

VEEV Stock Analysis - Frequently Asked Questions

Should I buy or sell Veeva Systems stock right now?: 20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" VEEV shares.
View VEEV analyst ratings or view top-rated stocks.
What is Veeva Systems' stock price target for 2024?: 20 brokers have issued 1 year target prices for Veeva Systems' shares. Their VEEV share price targets range from $160.00 to $270.00. On average, they predict the company's stock price to reach $234.90 in the next year. This suggests a possible upside of 17.2% from the stock's current price.
View analysts price targets for VEEV or view top-rated stocks among Wall Street analysts.
How have VEEV shares performed in 2024?: Veeva Systems' stock was trading at $192.52 at the start of the year. Since then, VEEV stock has increased by 4.1% and is now trading at $200.38.
View the best growth stocks for 2024 here.
When is Veeva Systems' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 29th 2024.
View our VEEV earnings forecast.
How were Veeva Systems' earnings last quarter?: Veeva Systems Inc. (NYSE:VEEV) announced its quarterly earnings data on Thursday, February, 29th. The technology company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.81 by $0.11. The technology company earned $630.62 million during the quarter, compared to the consensus estimate of $620.75 million. Veeva Systems had a trailing twelve-month return on equity of 11.26% and a net margin of 22.24%.
What ETFs hold Veeva Systems' stock?: ETFs with the largest weight of Veeva Systems (NYSE:VEEV) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Sterling Capital Focus Equity ETF (LCG), Fidelity Digital Health ETF (FDHT), Direxion Daily Cloud Computing Bull 2x (CLDL), ARK Genomic Revolution ETF (ARKG), VanEck Morningstar ESG Moat ETF (MOTE), VanEck Morningstar Wide Moat ETF (MOAT) and Goldman Sachs Future Health Care Equity ETF (GDOC).

What guidance has Veeva Systems issued on next quarter's earnings?: Veeva Systems issued an update on its first quarter 2025 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of 1.420-1.430 for the period, compared to the consensus EPS estimate of 1.270. The company issued revenue guidance of $640.0 million-$643.0 million, compared to the consensus revenue estimate of $645.8 million.
What is Peter Gassner's approval rating as Veeva Systems' CEO?: 202 employees have rated Veeva Systems Chief Executive Officer Peter Gassner on Glassdoor.com. Peter Gassner has an approval rating of 82% among the company's employees.
What other stocks do shareholders of Veeva Systems own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Veeva Systems investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), PayPal (PYPL), Shopify (SHOP), Walt Disney (DIS), Adobe (ADBE), Netflix (NFLX), Trade Desk (TTD) and Block (SQ).
Who are Veeva Systems' major shareholders?: Veeva Systems' stock is owned by many different institutional and retail investors. Top institutional shareholders include Los Angeles Capital Management LLC (0.09%), Rockland Trust Co. (0.06%), Thomasville National Bank (0.05%), Gateway Investment Advisers LLC (0.03%), Congress Asset Management Co. MA (0.02%) and Selective Wealth Management Inc. (0.02%). Insiders that own company stock include Alan Mateo, Eleni Nitsa Zuppas, Jonathan Faddis, Joseph Christopher Hays, Mary Lynne Hedley, Matthew J Wallach, Matthew J Wallach, Michele O'connor, Paul Edward Chamberlain, Paul J Sekhri, Peter P Gassner, Ronald E F Codd, Steven L Fasman, Thomas D Schwenger and Timothy S Cabral.
View institutional ownership trends.
How do I buy shares of Veeva Systems?: Shares of VEEV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Veeva Systems have any subsidiaries?: The following companies are subsidiares of Veeva Systems: AdvantageMS, Learnaboutgmp, Physicians World, Selligy, Veeva Crossix, Veeva RTSM, Veracity Logic, and Zinc Ahead Ltd.
Read More

This page (NYSE:VEEV) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial